m6Am and the cap-proximal position
The cap-proximal adenosine carries the same methyl group as internal m6A, one nucleotide away from the cap. Work on this position is usually about stability, decapping and cap identity — questions that need the cap-proximal signal separated from the internal one before either can be interpreted.
01The question
m6Am is the methylated form found on the first transcribed nucleotide behind the cap. It shares its chemistry with internal m6A, and that is what makes the position the whole point of the measurement: a signal over that adenosine and a signal over an adenosine in the transcript body are not the same observation, whatever the chemistry has in common.
The questions asked here are about the capped end — whether the cap-proximal position is methylated in a given condition, and whether that state tracks with how long a transcript survives or with how its capped end is handled. Because only one position per transcript carries the mark, the readout is naturally anchored rather than spread across the transcript.
02What the cap-proximal position is read against
- Transcript stability. Whether the methylation state of the cap-proximal adenosine moves with how long the transcript persists.
- Decapping and turnover. Whether the marked end is processed differently from the unmarked one.
- Translation initiation. Whether the state of the first nucleotide is reflected in how efficiently the transcript is engaged by the ribosome.
- Cap identity. The cap and the nucleotide behind it together form the 5′ signature a transcript presents, which is relevant to work on how foreign and self RNA are distinguished.
- Separation from internal m6A. Whether the effect being described belongs to the cap-proximal position at all, rather than to internal methylation of the same transcript.
03Which route reads the position
m6Am Modification Profile (m6Am-Exo-Seq)
An exonuclease step digests inward from the free end while the cap protects what sits behind it, so the reads report the capped end rather than the transcript body.
Cap-proximalno antibody INTERNAL m6Am6A Modification Seq (CAM-seq)
Where internal m6A on the same transcripts also matters, it is read on the single-base line so the two positions are not reported as one number.
Site-levelinternal SCREENm6A Modification Profile (MeRIP-Seq)
Enrichment-based profiling across transcripts, used when the question is which transcripts are involved rather than what happens at a given position.
Transcriptenrichment REFERENCEModification types
Where m6Am sits among the other marks and which method reads each one.
Reference14 marks04Readouts usually run alongside
Each of these is a separate measurement taken on the same material, not part of the modification assay itself.
Transcript half-life
A transcription-arrest time course measures how fast the transcript disappears, which is the quantity a stability claim is actually about.
Ribosome profiling
Reports translation efficiency, for work that connects the capped end to how the transcript is engaged.
Cap-proximal mapping
An independent look at the first nucleotides of the transcript, used to check that what the profile reports is where the method assumes the mark sits.
05Setting the study up
- Fix the position first: state that the claim is about the cap-proximal adenosine, not about m6A in general.
- Choose the route that separates the capped end from the transcript body, and check that the internal signal does not carry into the measurement.
- Pair the profile with one functional readout — stability or translation — taken on the same RNA.
- Keep the internal m6A question on the single-base line if both are being asked, so the two are reported as two quantities.
| What you want to conclude | Modification side | Request Quote |
|---|---|---|
| The cap-proximal position is methylated differently between conditions | Cap-proximal profile on matched samples | |
| Cap-proximal state tracks with transcript stability | Cap-proximal profile plus a half-life measurement | |
| Both cap-proximal and internal m6A matter | Cap-proximal profile plus a single-base m6A run |
06FAQ
Is m6Am just m6A at another position?
The chemistry is shared; the position is not. The cap-proximal adenosine is a single defined nucleotide per transcript, while internal m6A is distributed across the body of the transcript, so the two are measured and interpreted separately, and a route that does not separate them cannot report either one.
Does an enrichment-based m6A profile answer an m6Am question?
No. Standard enrichment does not separate the two positions, so a profile built that way cannot attribute its signal to either one. The route used here avoids the problem differently: the cap-proximal position is defined by the capped end itself, so the measurement is anchored at that nucleotide rather than at a binding preference.
Why does this route avoid an antibody?
Because the position is defined by the cap rather than by a binding preference. An exonuclease step keys on that structure — it digests inward from the free end while the cap protects what sits behind it — which is also why internal signal is depleted in the same reaction rather than only discarded in the analysis.
Does the readout give a per-transcript value or a per-site value?
It reports the cap-proximal status of transcripts. Where a resolved position with a ratio is the requirement, that is a different question and a different line, and the two can be run on the same material if a study needs both.